← Leaderboards
Brian R. Edlin
University Of California San Francisco
$15,097,905
Attributed
$15,097,905
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$15,097,905 · 12
By mechanism
R01$14,832,175 · 6
M01$265,730 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Kimberly Page$27,276,464
- Elise D Riley$16,115,559
- Cheryl Zlotnick$188,772
- David Roy Bangsberg$24,881,545
- Joseph M McCune$87,907,605
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CHepatitis C VirusHuman SubjectNeedle SharingClinical ResearchCommunitiesRecruitment ActivityInfectionInjecting Drug UserParticipantIntravenous Drug AbuseImmune ResponseRisk BehaviorsResponsePharmaceutical PreparationsEpidemicInjection Of Therapeutic AgentHigh Risk Behavior /LifestyleHigh RiskHiv InfectionsHuman MorbidityCommunicable Disease ControlAids Education /PreventionHealth Behavior
Grant awards (38)
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$674,840
R01 · FY2014 · DA · contact PI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$659,652
R01 · FY2013 · DA · contact PI
HCV Transmission among Young IDUs in NYC$592,608
R01 · FY2012 · DA · contact PI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$381,419
R01 · FY2012 · DA · contact PI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$311,828
R01 · FY2012 · DA · contact PI
HCV Transmission among Young IDUs in NYC$179,516
R01 · FY2012 · DA · contact PI
HCV Transmission among Young IDUs in NYC$829,591
R01 · FY2011 · DA · contact PI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$679,384
R01 · FY2011 · DA · contact PI
HCV Transmission among Young IDUs in NYC$834,093
R01 · FY2010 · DA · contact PI
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention$713,797
R01 · FY2010 · DA · contact PI
HCV Transmission among Young IDUs in NYC$824,042
R01 · FY2009 · DA · contact PI
HCV Transmission among Young IDUs in NYC$834,452
R01 · FY2008 · DA · contact PI
Acute HCV Infection in Injection Drug Users$400,039
R01 · FY2008 · DA · contact PI
Acute HCV Infection in Injection Drug Users$250,431
R01 · FY2008 · DA · contact PI
Acute HCV Infection in Injection Drug Users$724,814
R01 · FY2007 · DA · contact PI
ACUTE HEPATITUS C VIRUS INFECTION IN INJECTION DRUG USERS$19,075
M01 · FY2007 · RR · contact PI
TREATMENT OF HEPATITIS C VIRUS IN UNDERSERVED POPULATIONS$12,663
M01 · FY2007 · RR · contact PI
Acute HCV Infection in Injection Drug Users$733,105
R01 · FY2006 · DA · contact PI
ACUTE HEPATITUS C VIRUS INFECTION IN INJECTION DRUG USERS$156,377
M01 · FY2006 · RR · contact PI
TREATMENT OF HEPATITIS C VIRUS IN UNDERSERVED POPULATIONS$68,870
M01 · FY2006 · RR · contact PI
Acute HCV Infection in Injection Drug Users$50,257
R01 · FY2006 · DA · contact PI
Acute HCV Infection in Injection Drug Users$651,048
R01 · FY2005 · DA
Acute HCV Infection in Injection Drug Users$83,333
R01 · FY2005 · DA
TREATMENT OF HEPATITIS C VIRUS IN UNDERSERVED POPULATIONS$6,559
M01 · FY2005 · RR
ACUTE HEPATITUS C VIRUS INFECTION IN INJECTION DRUG USERS$2,186
M01 · FY2005 · RR
Acute HCV Infection in Injection Drug Users$640,563
R01 · FY2004 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$293,084
R01 · FY2004 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$805,514
R01 · FY2003 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$627,304
R01 · FY2002 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$125,241
R01 · FY2002 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$79,667
R01 · FY2002 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$36,561
R01 · FY2002 · DA
SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTION$529,848
R01 · FY2001 · DA
CLIN. &HISTOLOGIC SPECTRUM OF HCV LIVER DISEASE IN IDU$294,097
R01 · FY2001 · DA
HEPATITIS C VIRUS TRANSMISSION IN CRACK COCAINE SMOKERS$65,252
R01 · FY2001 · DA
SECONDARY SYRINGE EXCHANGE PEER MOBILIZATION INTERVENTIO$474,807
R01 · FY2000 · DA
CLIN. &HISTOLOGIC SPECTRUM OF HCV LIVER DISEASE IN IDU$351,843
R01 · FY2000 · DA
HEPATITIS C VIRUS TRANSMISSION IN CRACK COCAINE SMOKERS$100,145
R01 · FY2000 · DA